A Global to Rural Innovation Network to Adapt Evidence- Based Cardiovascular Interventions to Context
Principal Investigators
Chris Longenecker, MD
he/himUniversity of Washington
- Associate Professor of Medicine, Cardiology, and Global Health
- Director, Global Cardiovascular Health Program
- Director, Harborview HIV-Cardiology Clinic
- Attending Physician, Harborview Medical Center
University of Idaho
- Associate Director of Medical Research
- Clinical Associate Professor, Athletic Training
GROW-RURAL Project Aims
Aim 1: To develop a practice-based implementation research network incubator for cardiovascular health interventions in the rural Mountain West and Pacific Northwest. We will engage 52 rural [rural-urban commuting area (RUCA) code 3] and rural-serving [RUCA code 4] primary care practices to conduct research that will rapidly generate data on CVD care implementation strategies responsive to priorities in diverse rural communities. We will conduct a formative mixed-methods needs assessment that will inform a community-engaged design process to establish the network incubator. We will then iteratively redesign the network during the demonstration projects to develop a final sustainable model.
Aim 2 (Demonstration Project): To adapt a digital optimization toolkit for heart failure with reduced ejection fraction (HFrEF) and test its implementation in rural clinical practice. Rural US residents are less likely to receive optimal doses of guideline directed medical therapy (GDMT) for HFrEF and have lower access to technology (e.g. telemedicine) to overcome rural barriers to care. Frugal mHealth solutions for heart failure management have been successful in LMIC and could be adapted to the rural US along with tools to improve digital health literacy. Leveraging an AHA-funded project conducted in the US and Brazil and using a human-centered design approach, we will adapt a patient engagement smartphone app, an integrated remote patient monitoring solution, and provider-facing technologies to select rural WPRN practices and test implementation in a Type III hybrid implementation-effectiveness trial using an interrupted time series design. The primary implementation outcomes will focus on reach, effectiveness, adoption, implementation, and maintenance (RE-AIM). The primary effectiveness outcome will be GDMT score. University of Idaho (UI) will lead this aim.
Aim 3 (Demonstration Project): To adapt differentiated service delivery models for cardiovascular disease prevention and test implementation in rural clinical practice. Differentiated service delivery (DSD) is the idea that healthcare must be delivered by the right people in the right places at the right time to be most effective and efficient11. Many DSD models were developed in Africa to provide efficient client-centered HIV care, and may be adapted to CVD prevention care in the rural US (global to local). Other DSD models—like clinical pharmacist management of hypertension in Black barbershops—developed in US cities but potential rural correlates of the urban Black barbershop have not been fully explored. Using a similar human-centered design approach as in Aim 2, we will adapt differentiated service delivery models for evidence-based hypertension care from Uganda and urban US to address hypertension in rural WPRN practices (and possibly other Life’s Essential 8™ (LE8) measures of cardiovascular health if deemed a priority by communities during the design process). We will test implementation in a Type III hybrid trial with RE-AIM implementation outcomes. The primary effectiveness outcome will be blood pressure (BP) control. Montana State University (MSU) will lead this aim.